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Novel cell surface-reactive monoclonal antibodies generated against extrahepatic biliary cells were developed for the isolation
and characterization of different cell subsets from normal adult human gallbladder. Eleven antigenically distinct gallbladder
subpopulations were isolated by fluorescence-activated cell sorting. They were classified into epithelial, mesenchymal, and
pancreatobiliary (PDX1+SOX9+) subsets based on gene expression profiling. These antigenically distinct human gallbladder cell
subsets could potentially also reflect different functional properties in regards to bile physiology, cell renewal and plasticity.
Three of the novel monoclonal antibodies differentially labeled archival sections of primary carcinoma of human gallbladder
relative to normal tissue. The novel monoclonal antibodies described herein enable the identification and characterization of
antigenically diverse cell subsets within adult human gallbladder and are putative tumor biomarkers.
© 2015TheAuthors. PublishedbyElsevierB.V.This is anopenaccess articleunder theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The human gallbladder mainly functions to concentrate and
store bile, and like anatomically close-by organs—the liver andAbbreviations: CCKAR, cholecystokinin A receptor; EHBT, extra-
hepatic biliary tissue; EHBC, extrahepatic biliary cell; EPCAM,
epithelial cell adhesion molecule; GB, human gallbladder; GBCA,
gallbladder carcinoma; HPd, human pancreatic duct; KRT19, keratin
19; LMNA, lamin A/C; mAb, monoclonal antibody; MUC5B, mucin 5B,
oligomeric mucus/gel-forming; MYH11, myosin, heavy chain 11,
smooth muscle; PBGs, Peribiliary glands; PDX1, pancreatic and
duodenal homeobox 1; RAS, Rokitansky–Aschoff sinuses; SOX9, SRY
(sex determining region Y)-box 9; VIM, vimentin.
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).the pancreas—is derived from the foregut endoderm during
embryonic development (Spence et al., 2009). The extrahe-
patic biliary tree (comprising extrahepatic bile ducts, common
duct, cystic duct and gallbladder) shares a common progenitor
with the ventral pancreas during embryonic development
(Spence et al., 2009). In the adult, putative facultative stem/
progenitor cells are postulated to exist in injured liver (Dorrell
et al., 2008a, 2011a; Tarlow et al., 2014; Schmelzer et al.,
2007; Williams et al., 2014), pancreas (Xu et al., 2008), and
the extrahepatic biliary system (Manohar et al., 2011;
Cardinale et al., 2011, 2012; Carpino et al., 2012; Furuyama
et al., 2011).
The development of cell surface markers that label
different cell subsets in the liver and pancreas has facilitated
greater understanding of these cells and their roles within
their respective organ systems (Dorrell et al., 2008a,b,
2011a). In contrast, no cell surface markers have beenis an open access article under the CC BY-NC-ND license
173Surface-reactive monoclonal antibodies generated from gallbladderdeveloped specifically for normal adult human gallbladder or
the extrahepatic biliary tree to date. The availability of
antibodies that preferentiallymark cell populations within the
extrahepatic biliary systemwould allow the identification and
classification of these cells in relation to bile physiology,
gallstone formation, cell plasticity and renewal, metaplasia,
and tumor formation.
Here, novel monoclonal antibodies were developed to
detect cells originating from human extrahepatic biliary
tissues (EHBT) such as gallbladder and cystic duct. These
monoclonal antibodies allowed the visualization and isola-
tion of antigenically diverse subpopulations from adult
human gallbladder. Gene expression analyses of these
extrahepatic biliary cell (EHBC) subsets further indicated
distinct epithelial, mesenchymal, or pancreatobiliary traits.
Finally, survey of several primary carcinomas of human
gallbladder showed differential immunolabeling with respect
to normal gallbladder.
Materials and methods
Gallbladder and cystic duct specimens
Normal human gallbladder and cystic duct specimens
(collectively referred to as extrahepatic biliary tissues or
EHBT) were sourced from the Departments of Surgery and/or
Surgical Pathology at the Oregon Health & Science University
(OHSU). The pathologist on duty selected and excised grossly
normal EHBT fragments (1 cm2 to 3 cm2). These were kept
on ice in DMEM/F12 supplemented with 100 units/mL
Penicillin and 100 μg/mL Streptomycin (Mediatech, Manas-
sas, VA, USA). Tissue samples were anonymized as outlined
in the IRB study exemption approved by the OHSU Institu-
tional Review Board. Single cell suspensions of gallbladder
and cystic duct (collectively called extrahepatic biliary cells
or EHBC) were prepared by digestion of EHBT in 5 mg/mL
collagenase II (Gibco, Grand Island, NY, USA) in 1X HBSS
(HyClone Laboratories, South Logan, UT, USA), 20 μg/mL
DNaseI (Roche, Laval, QC, Canada) and 1% v/v HEPES
(Mediatech, Manassas, VA, USA) for a total of 2-hour
incubation in a 37 °C water bath. EHBT tissue chunks were
subsequently strained through a 100-micron nylon mesh (BD
Falcon, Bedford, MA, USA) and cells washed and treated with
ACK lysis solution (0.15 M NH4Cl, 10 mM KHCO3, 0.1 mM
EDTA, pH 7.4, filter-sterilized) for 2 min at room tempera-
ture to remove red blood cells. Finally, EHBC were washed
and strained using a 40-micron nylon mesh (BD Falcon,
Bedford, MA, USA) and resuspended in DMEM/F12 supple-
mented with 0.5% fetal bovine serum (Sigma-Aldrich, St.
Louis, MO, USA) and kept on ice. To archive tissues, EHBT
samples were cut into less than 1 cm2 fragments and
embedded in Tissue-tek cryomatrix (Sakura, Tokyo, Japan)
and stored at −81 °C. Formalin-fixed paraffin-embedded
(FFPE) tumor sections from anonymized primary human
adenocarcinoma of the gallbladder were obtained from the
OHSU Knight BioLibrary.
Antibody production
Animal husbandry and immunizations adhered to OHSU
Institutional Animal Care and Use Committee (IACUC) underapproved protocol A982. Female Balb/c mice (10 weeks old)
were immunized with 3 doses by intraperitoneal injection of
freshly isolated viable EHBC (5 × 105–3 × 106 cells per dose)
given 3 weeks apart. Mice were sacrificed four days after
the last dose and splenocytes were harvested and fused
with SP2/0 Ag14myeloma cells. Hybridoma clones were
grown in methylcellulose-containing HAT medium (Stem
Cell Technologies, Vancouver, BC, Canada) (Dorrell et al.,
2008b). A total of 427 isolated hybridoma clones were
generated, picked, and transferred to 96-well plates. Neat
supernatants were collected for screening by indirect immu-
nofluorescence on acetone-fixed frozen sections of human
EHBT. Clones of particular interest (Table 1) were cryopre-
served and expanded in culture in DMEM (Gibco, Grand Island,
NY, USA) supplemented with 10% v/v fetal bovine serum.
Antibody isotypes were determined using a direct horseradish
peroxidase-based mouse immunoglobulin isotyping ELISA kit
(BD Biosciences, San Diego, CA, USA).Immunofluorescence
Five-micron thick cryosections of adult human EHBT were
prepared using a Reichert 2800 Frigocut cryostat (Reichert
Scientific Instruments, Buffalo, NY, USA). Cryosections were
fixed in acetone for 5 min at −20 °C, allowed to dry at room
temperature, and stored at −81 °C for up to threemonths. One
hundred microliter volume of hybridoma supernatants were
utilized to label EHBT sections, washed with PBS, and followed
by stainingwith 0.5 μg/μL of Cy3- or AlexaFluor 488-conjugated
goat anti-mouse IgG (Jackson ImmunoResearch, West Grove,
PA, USA) in PBS supplemented with 5% (v/v) fetal bovine serum
(HyClone Laboratories, South Logan, UT, USA) and 5% (v/v) Rat
Serum (AbD Serotec, Raleigh, NC, USA). Slides were washed
with 1X PBS prior to mounting with a solution containing 10%
glycerol and 4% N-propyl gallate with 0.001% (v/v) Hoechst
33342 (Sigma-Aldrich, St. Louis, MO, USA). Slides were
evaluated using a Zeiss Axioskop 2 plus microscope (Carl Zeiss,
Jenna, Germany).
For pancytokeratin (PanCK) staining, a rabbit polyclonal
antibody for wide-spectrum cytokeratin (Abcam, Cambridge,
MA, USA) was used in combination with GB1, GB5, and HPd3
following the standard use of hybridoma supernatants in
indirect immunofluorescence of acetone-fixed EHBT stated
above.
For FFPE-tumor sections, slides were heated to 60 °C for
15 min. Sections were deparaffinized in xylene at room
temperature for 15 min and rehydrated by soaking for
4 min at room temperature in various concentrations of
ethanol (100%, 95%, 70%, and 50%), rinsed in deionized
water and stored in 1X PBS (Fisher Scientific, Fish Lawn, NJ,
USA). For antigen retrieval, sections were immersed in
citrate buffer (10 mM citrate, pH 6.2, 2 mM EDTA, 0.05%
Tween-20) using glass staining dish and heated in a
microwave oven for 3 consecutive 5-min cycles at power
levels 5, 5, and 4. The dish was allowed to cool down to
room temperature and tissue sections were rinsed twice in
1X PBS (Long and Buggs, 2008). Sections were blocked with
5% v/v normal goat serum (Jackson ImmunoResearch, West
Grove, PA, USA) in 1X PBS for 2 h at room temperature,
and rinsed twice with PBS prior to immunohistochemical
labeling as the above.
Table 1 Monoclonal antibodies reactive to antigens in human extrahepatic biliary cells (EHBCs).
Antibody Immunofluorescence staining patterns in gallbladder and cystic duct Antibody
isotype
(Mouse)
Frequency of positive cells
Gallbladder Cystic duct
GB1* Subset of mucosal epithelium IgG 2% 1%
GB2* All mucosal epithelium with apical bias IgG 8% 3%
GB3* Subset in the muscularis layer; subset of peribiliary glands IgM 6% 6%
GB4* All mucosal epithelium + peribiliary glands and surrounding connective tissues IgG 5% 2%
GB5* Mucosal epithelium with basal bias IgG 5% 2%
GB6* All mucosal epithelium + subset of lamina propria + peribiliary glands and
surrounding connective tissues
IgM 80% 80%
GB7* Mucosal epithelium with subcellular localization IgM 1% b1%
GB8* Mucosal epithelium with subcellular localization IgM 2% 1%
GB9 Subset of mucosal epithelium IgM 6% 2%
GB10 Subset of mucosal epithelium with apical bias + peribiliary glands IgG 3% 2%
GB11 Mucosal epithelium IgM 7% 2%
GB12 Mucosal epithelium with apical bias IgG 10% 3%
GB13 Mucosal epithelium IgG 9% 3%
GB14 Secreted/luminal N.D. 0 0
GB15 Circumference of large blood vessel walls IgM b1% b1%
GB16 Mucosal epithelium, peribiliary glands IgG 4% 2%
GB17 Subset of mucosal epithelium with apical bias IgM 2% 1%
GB18 Mucosal epithelium with apical bias; peribiliary glands IgG 7% 2%
GB19 Subset of mucosal epithelium with apical bias N.D. 0 0
GB20 Mucosal epithelium and subsets in the muscularis layer IgG 8% 4%
Antibodies marked with asterisks (*) were selected for dual labeling fluorescence-activated cell sorting to subdivide adult human EHBCs.
GB = human gallbladder. N.D. not determined.
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Dissociated EHBC were incubated in hybridoma supernatant
for 30 min at 4 °C and washed with cold DMEM prior to
labeling with anti-mouse secondary antibodies, namely:
PE-conjugated anti-mouse IgM and DyLight488-conjugated
anti-mouse IgG (Jackson ImmunoResearch, West Grove, PA,
USA). Propidium iodide (10 μg/mL) (Molecular Probes, Eu-
gene, OR, USA) was included to the cell suspensions to mark
dead cells. Cells were analyzed with a FACSCalibur or sorted
by Influx-GS (BD Biosciences, San Jose, CA, USA) at 15 psi using
a 100-μmnozzle. The software FlowJo (Treestar, Ashland, OR,
USA) was utilized to analyze flow cytometric data.
RT-qPCR
FACS-sorted cells were collected into Trizol LS (Invitrogen,
Carlsbad, CA, USA). Total RNA was extracted by following
the manufacturer's recommended protocol. First strand
cDNA was synthesized utilizing random oligonucleotides
and M-MLV reverse transcriptase (Invitrogen, Carlsbad, CA,
USA) as directed by the manufacturer. SYBR-based quanti-
tative PCR was performed by utilizing either iQ™ 5 or CFX96
Touch™ Real-Time PCR Detection System (Bio-Rad, Hercules,
CA, USA) to measure gene expression. The qPCR reactions
comprised Platinum® Taq polymerase, 2.5 mM MgCl2, 10 μM
DNA primers, 10 mM dNTPs, and 0.5X SYBR green (Invitrogen,
Carlsbad, CA, USA). Thermocycling reactions were run as
follows: 45 cycles of 15 s at 95 °C, 20 s at 68 °C, and 25 s
at 72 °C. The following are the primers used: LMNA (5′,
agatgcgggcaaggatgcag, 3′, cctcctcgccctccaagagc), ACTB(5′,cacccgccgccagctcac, 3′, atcacgccctggtgcctggg), RPL32 (5′,
tctccttctcggcatcatggccg, 3′,tgggtttccgccagttacgct), EPCAM (5′,
ttgccgcagctcaggaagaa, 3′, tttggcagccagctttgagc), MUC5B
(5′, ctgggagaatgcagggcaca, 3′, ggctcaggctggggaagaca), PDX1
(5′, tggaggagcccaaccgcgtccagc, 3′, gcgccgcctgcccactgg
cctt), CCKAR (5′, gcaggcaaggatggatgtgg, 3′, ccagcacg
ctgagcaggaat), MYH11 (5′, gggcggagctcaatgacaaa, 3′,
aagcagctcctgggtgtcctg), KRT19 (5′, cctcccgcgactacagcc
acta, 3′, ccacttggcccctcagcgta), VIM (5′, agctcaaggg
ccaaggcaagtc, 3′, tctcctcctgcaatttctcccg), SOX9 (5′, gcgg
cccttcgtggaggaggcgga, 3′, tgggattgccccgagtgctcgccgg).
Gene expression values were calculated as the difference
between baseline-corrected, curve-fitted threshold cy-
cles (Cq) of the genes of interest subtracted by the mean
Cq of reference genes (LMNA, RPL32, ACTB).
Results
Antibody screening of human gallbladder and
cystic duct
A total of 427 hybridomas were produced after serial
immunization of Balb/c mice with dispersed cells from
human EHBT. Antibody-containing supernatants from each
hybridoma clone were then screened for reactivity by indirect
immunofluorescence in acetone-fixed EHBT sections (adult
human gallbladder and cystic duct). The frequency of clones
with extrahepatic biliary tissue labeling was 36.8% (157 out of
427). The majority of the 157 positive mAbs stained cell
subsets (147/157), while the remainder labeled the entire
gallbladder or cystic duct tissue sections (10/157).
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with areas of (a) mucosal epithelium characterized by apical/
luminal staining and/or basolateral staining, (b) Rokitansky–
Aschoff sinuses (RAS) (Terada, 2013), (c) generalized or patchy
staining encompassing themucosa, lamina propria, muscularis
and the adventitial or subserosal layers, (d) submucosal
structures in the cystic duct called peribiliary glands (PBGs),
and (e) blood vessel walls (BV) (Fig. 1A, Table 1 and Suppl.
Figs. 1–2).
Flow cytometric analyses in dispersed gallbladder
and cystic duct cells
Seventy-eight mAb clones were selected for further analyses
by flow cytometry based on staining intensity and
immunolabeling of discrete groups of cells found in the
mucosal, muscular, and adventitial/serosal layers (Fig. 1A and
Suppl. Figs. 1–2). Further cross-referencing the immunolabeling
patterns and intensities of the 78 mAbs yielded 20 distinctive
mAbs, which were analyzed in single cell suspensions of liveFigure 1 Immunofluorescence labeling patterns in adult human g
and top middle panels) with characteristic outpouching (also known
the muscularis layer. Also, GB21 selectively labeled mucosal epithel
marked peribiliary glands (PBGs) (bottom middle). GB15 labeling o
ductal surface antibodies labeled gallbladder mucosal epithelium.extrahepatic biliary cells (EHBCs) from both gallbladder and
cystic duct to determine cell surface reactivity. Seventeen of
the 20 mAbs had surface reactivity in at least 1% of cells while
onemAb labeled less than 1% of total EHBCs. The remaining two
mAbs failed to label live dispersed EHBCs (Table 1).
Several of the antibodies raised (GB1, 2, 5, 7, 8, 9, 11, 12,
13, and 17) were useful for FACS-mediated isolation of purely
epithelial cells derived from the gallbladder and cystic duct
(Table 1). Importantly, some antibodies specifically labeled
only subpopulations of the mucosal epithelium (GB1, 9, and
17), demonstrating that the epithelial layer of the gallbladder
mucosa is comprised of antigenically heterogeneous cell
types, not obvious with hematoxylin and eosin staining or
even pancytokeratin immunolabeling (Fig. 3).
Comparative immunofluorescence of EHBT and
human pancreas
Given the anatomic and developmental proximity of the EHBT
to the pancreas, we tested surface antibodies generatedallbladder. A) The mAb GB2 labeled mucosal epithelia (top left
as Rokitansky–Aschoff sinuses (RAS)) (top right) extending into
ium (bottom left), but without the apical bias of GB2. GB5 mAb
f a blood vessel (BV) wall (bottom right). B) Three pancreatic
176 F.H. Galivo et al.against human cytokeratin-19+ pancreatic ductal cells (HPd1
and HPd3) (Dorrell et al., 2008b, 2011b) that were also tested
on acetone-fixed sections of EHBTs, along with another
pancreatic duct marker HPd4 and our new antibodies. All
three pancreatic duct mAbs also labeled the epithelial cells of
the gallbladder mucosa (Fig. 1B).
Twenty-nine of the gallbladder mAbs were further tested
in acetone-fixed human pancreatic tissue sections with 27
mAbs labeling extensive areas of the pancreas (e.g. ducts,
exocrine cells, blood vessels, and Islets of Langerhans)
(Suppl. Fig. 3). The remaining two mAbs (GB26 and 27)
labeled sparse areas (small subsets of cells) in the human
pancreas. These data infer that majority of these mAbs
generated against EHBT cross-react with pancreatic cells
suggesting shared antigens with gallbladder and cystic duct.
FACS isolation of gallbladder subpopulations
Next, the list of twenty mAbs was further narrowed to eight
GB mAbs for fluorescence-activated cell sorting (FACS) in
combination with the pancreatic ductal mAb HPd3 to
potentially subdivide EHBCs into discrete subpopulations
(Fig. 2A). For dual labeling, combined IgG and IgM primary
antibodies were distinguished using isotype-specific second-
ary antibodies (Table 1). This method identified eleven
clearly distinct subpopulations in live EHBCs (Fig. 2A and
Table 2). Dual immunofluorescence in acetone-fixed sec-
tions of human gallbladder (Fig. 2B) was able to visualize
these same populations and their in situ frequency was
similar to their abundance as measured by FACS in dispersed
cell suspensions (Fig. 2A).
Gene expression analysis
The eleven antigenically distinct EHBC subsets isolated by
FACS had distinct gene expression patterns by RT-qPCR and
could be characterized as predominantly epithelial (epithelial
(EPCAM+, KRT19+)), ductal (SOX9+), mesenchymal (VIM+,
MYH11+), gallbladder (MUC5B+, CCKAR+), or pancreatobiliary
(PDX1+SOX9+) (Figs. 3A–D and Table 2).
Mixed epithelial subsets
Six different EHBC subsets (GB6+GB2+, HPd3+GB2+,
GB1+GB3−, GB8+GB4−, GB5+GB7+, and GB5+GB7−) were
similarly enriched for MUC5B, SOX9, and PDX1mRNA relative
to unsorted EHBC and EHBT (Figs. 3B–D). Immunofluores-
cence of EHBT acetone-fixed sections showed co-labeling of
pancytokeratin with GB2, GB5, and HPd3 (Figs. 3E–G), but
not with GB7. Furthermore, VIM expression was very low to
absent in these EHBC subtypes (Fig. 3C). Together, these
data demonstrate that these six cell populations represent a
subset of epithelial cells with low expression of EPCAM and
KRT19 but high levels of SOX9, MUC5B and PDX1.
PDX1+SOX9+ subsets
Notably, the GB8+GB4− and GB5+GB7+ subsets differed from
other fractions in that they had very high PDX1 mRNA levels
measured at 33.4% and 34.6% compared to human pancreatic
islet cells. Moreover, the PDX1 mRNA expression levels in
these populations were 23-fold and 24-fold enriched com-
pared to unsorted EHBCs, respectively. Similarly, anothersubset (GB1+GB3−) also had 14.5-fold enrichment of PDX1
mRNA with respect to unsorted EHBCs (Fig. 3D). Furthermore,
these same three PDX1+ subsets had 2.5-fold to 4.6-fold higher
expression of SOX9 compared to unsorted EHBCs (Fig. 3B).
Mixed epithelial–mesenchymal subset
Interestingly, the subpopulation GB1−GB3+ (which we desig-
nated as mixed epithelial–mesenchymal) (Table 2), had a
relatively high EPCAM, MUC5B, and VIM mRNA content but
absent expression of KRT19, SOX9, and PDX1 (Figs. 3A–D).
This is consistent with the observation that GB3 marks a
subset in the peribiliary glands and the muscularis layer
(Table 1).
Human gallbladder adenocarcinoma
In addition to the identification of antigenically heteroge-
neous epithelial subpopulations in EHBT, we were interested
in the cellular subset distribution of tumors. Our eleven novel
surface-reactive antibodies were tested in formalin-fixed,
paraffin-embedded (PPFE) sections of 5 primary adenocarci-
noma arising in the human gallbladder (GBCA) (Suppl. Table
1). Three different types of antigen-retrieval procedures were
performed in FFPE sections of both primary tumors and normal
tissues from human gallbladder, but only 5 mAbs (GB1, GB3,
GB7, GB8, and HPd3) successfully worked to label FFPE
sections (Fig. 4).
GB3 staining in tumors
The antigen stained by GB3 was evenly distributed in a
patchy fashion throughout the different layers of normal
gallbladder, particularly areas in proximity to the basement
membrane of mucosal epithelium, small blood vessel walls in
the muscularis, and areas in between (Fig. 4B, left panel).
However, this regular labeling pattern was lost in the four
(out of five) primary adenocarcinomas of human gallbladder
(GBCA) tested. Instead, GB3 labeling was restricted to the
luminal areas of mucosal epithelium proliferation and some
areas near blood vessels (Fig. 4B, middle and right panels).
This differential antigen localization (basal to luminal) may
be a potential marker of malignancy or tumor-associated
antigen in the gallbladder.
GB1 and GB8 staining in tumors
Similarly, two other antibodies (GB1 and GB8) had marked
luminal-staining bias in tumor sections (Fig. 4A, D, middle
and right panels), which was less evident in normal
gallbladder tissues (Fig. 4A, D, left panels). In one invasive
GBCA sample, distinctive extracellular circular bodies were
found in the luminal space and were stained by both GB1 and
GB8 antibodies (Fig. 4E).
GB7 Antibody
GB7 labeling of FFPE sections of both normal and tumor
samples was not drastically different in the small sample size
of primary gallbladder tumors tested (Fig. 4C).
Discussion
We have generated novel monoclonal antibodies from human
EHBT that are useful for the visualization and isolation of
Figure 2 Isolation of subpopulations from adult human gallbladder. A) Flow cytometric dotplots of human EHBC subsets subdivided
by GB2 and GB6 (top left), GB2 and HPd3 (top middle), GB4 and GB8 (top right), GB5 and GB7 (bottom left), and GB1 and GB3 (bottom
middle). B) Dual-immunofluorescence staining of acetone-fixed EHBT. Right panels depict merged images.
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gallbladder and cystic duct. The patient-derived material
for immunization was prepared to enrich for epithelial cells,
so it was not surprising to see that majority of the antibodies
labeled mucosal epithelia in EHBTs. The immunostaining
patterns in both gallbladder and cystic duct indicate
antigenic heterogeneity in the mucosal epithelium, whichmay further signify functionally distinct subsets. Moreover,
submucosal structures in the cystic duct called peribiliary
glands or PBGs were easily identifiable by some of these
mAbs. PBGs had been shown to harbor biliary progenitor
cells that are capable of differentiating into hepatocyte-like,
cholangiocyte-like, or pancreatic islet-like cells (Cardinale
et al., 2011; Carpino et al., 2012). FACS-enrichment of
Table 2 Immunofluorescence labeling frequencies and gene expression analysis of FACS-sorted extrahepatic biliary cells.
Subpopulations Frequency of
sorted cells ⁎
Relative mRNA expression § Gene expression summary #
EPCAM KRT19 SOX9 PDX VIM §
VIM VIM VIM EPCAM
GB6+GB2− 75.8% 0 8.8e-6 9.8e-3 ∞ 1.08 VIMhi, MYH11hi (mesenchymal)
GB6+GB2+ 14.2% 6.14 9.03 2.51 2.56 0.11 EPCAM+, SOX9hi, KRT19hi, MUC5B+, PDX1+ (mixed epithelial)
GB6−GB2− 3.5% 0.065 0.21 0.067 0 1.35 VIMhi, MYH11+ (mesenchymal)
HPd3−GB2− 89.9% 1.5e-4 7.7e-4 3.7e-3 0.34 1.25 VIMhi (mesenchymal)
HPd3+GB2+ 4.5% 51.2 86.1 20.5 0.016 0.013 EPCAM+, SOX9hi, KRT19hi, MUC5B+, PDX1+ (mixed epithelial)
GB1+GB3− 1.3% 24.6 17.7 13.0 0.064 0.022 EPCAM+, SOX9hi, KRT19+,MUC5B+, PDX1hi (mixed epithelial)
GB1–GB3+ 1.1% 1.07 0 8.1e-3 0 3.43 EPCAMhi, VIMhi, MUC5Bhi (mixed epithelial–mesenchymal)
GB8+GB4− 4.0% 11.6 13.2 6.18 0.061 0.077 PDX1hi, SOX9hi, CCKARhi, (pancreatic–biliary)
GB8−GB4− 94.7% 0.057 0.074 0.024 0.024 1.30 VIMhi, MYH11hi (mesenchymal)
GB5+GB7+ 1.3% ∞ ∞ ∞ 0.30 0 PDX1hi, SOX9hi, MUC5Bhi (pancreatic–biliary)
GB5+GB7− 14.3% 23.3 25.0 5.82 8.8e-3 0.034 EPCAM+, KRT19+, SOX9+ (epithelial)
Unsorted EHBC n.a.□ 0.14 0.89 0.058 9.1e-3 1.77 KRT19hi, MYH11hi, VIMhi, CCKARhi (mixed epithelial–
mesenchymal)
EHBT n.a.□ 0.59 3.25 4.1e-3 7.4e-4 3.58 EPCAMhi, KRT19hi, MYH11hi, VIMhi, CCKARhi (mixed
epithelial–mesenchymal)
⁎ As percentage of live extrahepatic biliary cells (EHBCs); Live cells were sorted as propidium iodide (PI) negative cells.
§ Relative mRNA expression was calculated based on qPCR ΔCq values, which are the differences between the Cq of the gene of interest
and the Cq of housekeeping genes LMNA, RPL32, and ACTB.
# Mesenchymal characteristic was designated if the ratio of epithelial/ductal markers (EPCAM, KRT19, SOX9) to Vimentin was less than
one, otherwise, a designation of predominantly epithelial was given. In addition, a pancreatic or gallbladder designation was given if
relative expression of “pancreatic” (PDX1) or “gallbladder” genes (MUC5B, CCKAR) was greater than that of unsorted EHBCs.
□ n.a.: not applicable.
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mAbs.
Our new mAbs were tested primarily in EHBCs from the
gallbladder and cystic duct because these structures are
some of the most accessible for research (anatomically and
specimen availability) within the hepatobiliary tree. We
have no direct evidence as to the specificity of these mAbs
to only the EHBCs versus intrahepatic biliary cells. Given the
anatomic continuity of the EHBT to the intrahepatic biliary
tree (IHBT), we predict that some of these mAbs may react
with the IHBT. Several groups had shown that PBGs in the
EHBT are marked by CK7, CK19, NCAM, CD133, EPCAM, SOX9,
and SOX17, which are also some of the major markers of
IHBT (Cardinale et al., 2011; Dianat et al., 2014). On the
other hand, another study showed that human intrahepatic
biliary duct cells and gallbladder cells expanded in vitro had
differing phenotypes and gene expression profiles (Manohar
et al., 2015), which also suggest that some of the mAbs may
be non-reactive to IHBT. Therefore, identification of the
target antigens of GB Abs and future testing in IHBT could
provide evidence of parallel or distinct biliary cell subsets
within the liver.
The cross-reactivity of pancreatic ductal Abs in EHBT and
GB Abs in ductal, exocrine, and endocrine pancreatic cells
indicates that similar antigens are shared between pancreas
and gallbladder/cystic duct cells. It is noteworthy that some
gallbladder subsets highly express PDX1. PDX1 is known to be
expressed in pancreatic endocrine and some duct cells and
may identify a more primitive population (Li et al., 2010).
Aside from the close developmental ontogeny with the
pancreas, the functional significance of PDX1 expression in
adult human EHBCs is not fully known (Cardinale et al.,2011; Carpino et al., 2012). It can be speculated that these
cells may be more amenable to genetic reprogramming
towards the pancreatic endocrine and could be a target for
regenerative medicine in diabetes (Hickey et al., 2013; Coad
et al., 2009).
The antibodies may also have use in the diagnosis and study
of gall bladder tumors. In general, themore intense labeling of
apical mucosa of GBCA samples by GB1, GB3, and GB8 suggests
that their antigens are upregulated in human gallbladder
tumors, and are candidates to be tumor-associated antigens.
Moreover, the apical membrane staining spilled into the
lumen of GBCA sections, which indicates that the antigen may
be shed or secreted into the lumen and could potentially find
its way into the digestive tract. Whether this luminal-staining
pattern, which was only evident in tumor tissues but not
normal controls, has any promise for identifying gallbladder
cancer biomarker(s) will depend on further extensive studies
and identification of the antigens. Overall, our immunofluo-
rescence studies on primary GBCA suggest that additional
evaluation of themAbs is warranted in other carcinomas of the
GI tract.Summary
The gallbladder cell subtype-marking antibodies described
here have revealed antigenic and transcriptional heterogene-
ity within the human gallbladder and cystic duct. Heteroge-
neity within the epithelial cells of the human gallbladder and
cystic duct was demonstrated by flow cytometric, immuno-
fluorescence, and gene expression analyses. Currently the
functional/physiological significance of these EHBC subsets
Figure 3 Gene expression characteristics of human EHBC subsets via RT-qPCR. Bar graphs depict the relative mRNA expression of
human EHBC cell subsets, as measured by the following genes of interests: EPCAM and KRT19 (A), SOX9 and MYH11 (B), MUC5B and
VIM (C), PDX1 and CCKAR (D). Gene expression levels were normalized to reference genes LMNA, RPL32, and ACTB.
Immunofluorescence co-labeling of Pancytokeratin (PanCK) with GB2 (E), GB5 (F), and HPd3 (G) in acetone-fixed sections of adult
human gallbladder.
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Figure 4 Immunofluorescence labeling of formalin-fixed paraffin-embedded (FFPE) human gallbladder. PPFE sections of both
normal (left panels) and primary carcinoma (middle and right panels) were amenable to immunofluorescence with GB1 (A), GB3 (B),
GB7 (C), and GB8 (D). Tumor samples labeled with GB1 and GB8 were found to have distinctive circular extracellular aggregates (E).
180 F.H. Galivo et al.remains unknown. In the future the ability to subdivide
antigenically different epithelial cells of the gallbladder
may be useful in dissecting the normal and pathologicphysiology of this organ as it relates to bile transport,
processing, stone formation, cellular plasticity, and cancer
development.
181Surface-reactive monoclonal antibodies generated from gallbladderSupplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2015.06.004.
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